INTRODUCTION
Coriandrum sativum L. (Family: Apiaceae) is a small, erect, branched, sweet smelling, perennial herb that is widely distributed in South Asia, the Mediterranean region, and in America. It is commonly known as coriander, phakchi, Chinese parsley, cilandrio, and cilantro. In the traditional systems of medicine, formulations containing CS seed have been used in the management of rheumatoid arthritis and other infl ammatory diseases. [1] [2] [3] Though widely used in the traditional systems of medicine, experimental studies with this plant are scarce. The anti-infl ammatory activity of this plant extract has been demonstrated in carrageenan-induced paw edema in experimental animals. [4, 5] In a recent study from our laboratory, we demonstrated the disease-modifying activity of Coriandrum sativum hydroalcoholic extract (CSHE) in complete Freund's adjuvant (CFA)-induced arthritis in Wistar rats. [6] Disease markers, viz., joint swelling, serum and synovial expression of pro-inflammatory cytokines (predominantly secreted by macrophages), were found to be reduced in the CSHE-treated animals as compared to arthritis control. However, in this model, there is an involvement of different types of pro-infl ammatory cells in development of the disease state. [7, 8] A reduction in these disease markers was also observed in the indomethacin-treated animals. Therefore, it could not be defi nitely concluded whether the anti-infl ammatory activity or the disease-modifying activity of the test drug was primarily responsible for the observed effects.
This study was thus designed to evaluate the involvement of anti-inflammatory activity of CSHE at the doses tested. Carrageenan-induced paw edema model was used to evaluate the effect of CSHE on autacoid mediators of infl ammation. Among pro-infl ammatory mechanisms associated with the development and progression of granulomatous disorders such as rheumatoid arthritis, macrophage activation and dysfunction, are known to be central players. [8, 9] Therefore, the disease-modifying activity of CSHE was evaluated in terms of its anti-macrophage activity. Subcutaneous cotton pellet implantation-induced granuloma formation was used for evaluation of anti-macrophage activity as this model is depictive of circulating macrophage activation and aggregation. [10] 
MATERIALS AND METHODS

Animals
Adult male Wistar albino rats (150-180 g) from our institutional breeding stock were used in the study. Animals were housed at 25°C2°C in clean polypropylene cages in batches of three with free access to standard pellet diet and drinking water. Experiments were carried out after approval by the Institutional Animal Ethics Committee, All India Institute of Medical Sciences, New Delhi, in accordance with "Guidelines for care and use of animals in scientifi c research (Indian National Science Academy 1998, Revised 2000)."
Test drug
In a previous report from our laboratory, we demonstrated the anti-arthritic activity of the test drug CSHE in experimental models. [6] The same test drug was employed in the present study. Briefly, the dried seeds of CS were obtained from the local market and authenticated by Professor Mohammad Ali, pharmacognosist and phytochemist at Jamia Hamdard University, New Delhi, India, as C. sativum L. (Family: Apiaceae), and a voucher specimen (PRL/JH/08/04) was submitted at the herbarium for future reference. The seeds were coarsely grounded and the powder was extracted by cold maceration with 50% v/v methanol for 72 h. The slurry was fi ltered through cotton wool to separate the suspended particles. The solvent was then evaporated under reduced pressure till a resinous extract was obtained. The extract was golden brown in color and the total quantitative yield was 13.86% w/w. CSHE was further subjected to pharmacognostical standardization for detection of secondary plant metabolites [11] and was found to contain sugars, alkaloids, tannins, resins, fl avonoids, fatty acids, and sterols. Toxicity studies previously carried out with the plant extract demonstrated an oral LD 50 value 2,000 mg/kg in rats. [6] No overt physiological changes were observed in any of the CSHE-treated animals after oral administration of the plant extract at a dose of 160 mg/kg for 28 days. [6] Induction of paw edema by carrageenan administration After acclimatization to the laboratory conditions, animals were divided into fi ve groups (n6) and fasted overnight with access to water ad libitum. Baseline paw volume recording was carried out using a digital plethysmometer (Ugo Basile, Italy). Thereafter, group I received vehicle (2 mL/kg body weight 1% gum acacia) and served as the control, group II received indomethacin (3 mg/kg body weight), and groups III, IV, and V received CSHE at a dose of 8, 16, and 32 mg/ kg body weight, respectively. Dose selection of the test drug was done on the basis of our previous report. [6] Sixty minutes after administration of the vehicle/drug, experimental paw edema was induced by subcutaneous administration of 0.1 mL of 1% -carrageenan (freshly constituted in normal saline) into the left hind paw of the animal. [12] Paw volume was again measured at 1 h, 3 h, and 6 h post-carrageenan administration. Paw edema was determined as described by us in a previous study.
[ 13] Induction of granuloma formation by subcutaneous cotton pellet implantation Animals were divided into five groups (n  6) and maintained under aseptic condition for the entire duration of the study. After overnight fasting, group I received vehicle (2 mL/kg body weight 1% gum acacia) and served as control, group II received indomethacin (3 mg/kg) and groups III, IV, and V received CSHE at a dose of 8 mg/kg, 16 mg/kg, and 32 mg/kg, respectively. Thirty minutes after administration of drug/vehicle, the animal was anaesthetized with diethyl-ether and a sterile cotton pellet (made from bleached cotton weighing 301 mg) was implanted subcutaneously, bilaterally under the axilla. [13] This was designated as day 0. Drug/vehicle treatment of the respective groups was continued for 6 more days. On day 7, terminal blood collection was carried out and the cotton pellets were excised. Serum was separated by centrifuging at 3,000 rpm and used for estimation of circulating cytokines by enzyme linked immune sorbent assay (ELISA) and dot blot analysis. The cotton pellets were dried overnight in a hot air oven (60°C) till a constant weight was recorded at two consecutive time points. The difference between the initial and post-implantation weight was considered to be the dry weight of granuloma tissue. [14] Estimation of serum tumor necrosis factor- levels Tumor necrosis factor- (TNF-) level was estimated in serum of treated animals using a commercially available ELISA kit (U-CyTech Biosciences, The Netherlands) as per the manufacturer's instructions.
Estimation of serum IL-6 and IL-1  levels
Measurement of circulating IL-6 and IL-1  protein was carried out by dot-blot analysis in serum of control, indomethacin, and highest dose CSHE (32 mg/kg) treated animals. [13] Briefl y, 3 L of serum from each sample was diluted to 10 L with 10 mM PBS (pH 7.2) and spotted on to nitrocellulose membranes and dried at room temperature. After blocking the non-specifi c sites, the cytokines were detected with anti-IL-6/anti-IL-1  polyclonal primary antibody (Santa Cruz Biotechnology, Inc, Santa Cruz, USA) followed by corresponding (Horse Radish Peroxidase) HRP-conjugated secondary antibody (Bangalore Genei, India). The blots were developed with nickel-enhanced DAB (di-aminobenzidine) substrate (Vector Labs, USA). Cytokine protein expression was measured by determining the intensity of darkness of dots by a densitometer (Alpha Imager EC Gel Doc System, CA, USA) using Alpha-View imaging software.
Stimulation of peritoneal macrophages
Three groups (n3) of male Wistar albino rats were used in this study. Peritoneal macrophages were stimulated according to the method described by us earlier. [13] After overnight fasting, group I was administered vehicle (2 mL/kg 1% gum acacia) and served as the control, group II was administered indomethacin (3 mg/kg), and group III was administered CSHE (32 mg/kg) by gavage. Thirty minutes post-administration of drug/vehicle, 0.1 mL of CFA (0.05% w/v dead Mycobacterium butyricum in mineral oil) was injected into the peritoneal cavity using a 26-gauge needle. [15, 16] This was designated as day 0. Drug/ vehicle administration was continued for 6 more days.
Isolation and culture of rat peritoneal macrophages
On day 7, animals were sacrifi ced by an overdose of anesthetic ether. Sterile RPMI 1640 media (10 mL) was injected into the peritoneal cavity and the abdomen was massaged for 5 min. The media was then aspirated under sterile conditions and transferred into a 15 mL centrifuge tube. The cellular content was pelleted out by centrifuging at 1,000g for 10 min at room temperature. The pellet was re-suspended and cultured aseptically in 60 mm culture dishes as described by us earlier. [13] The supernatant was then discarded and the adherent macrophages were washed twice with ice cold 10 mM PBS and scraped off. Culture purity of macrophages was determined according to the method of Ernist and Jones as described earlier. [13, 17] Preparation of cell lysate and western blotting
The macrophage pellet was lysed by strong vortexing in 100 L of lysis buffer containing 50 mM Tris-HCl (pH 7.4), 300 mM NaCl, 0.5% (v/v) Triton X-100, 5 mM EDTA with 2 mM PMSF, 10 g/mL leupeptin, and 10 U/mL aprotinin. The lysate was then kept on ice for 30 min and centrifuged at 10,000g for 15 min at 4°C. Supernatant was collected and protein concentration was determined by Bradford method [18] using bovine serum albumin as the standard.
Seventy-five microgram of protein was separated in 12% polyacrylamide gels (1.0 mm thick) overlaid with 4% stacking gel in SDS according to the standard procedure of Laemmli. [19] The separated proteins were then transferred onto nitrocellulose membrane under an electric potential. [20] After blocking the non-specifi c sites, detection of TNF-R1 and -actin protein expression was carried out using anti-TNF-R1 or anti--actin polyclonal primary antibody (Santa Cruz Biotechnology, Inc, Santa Cruz, USA), HRP-conjugated polyclonal secondary antibody (Bangalore Genei, India), and femtoLUCENT detection kit (G-Biosciences, USA). [13] Protein expression was quantifi ed by determining the intensity of darkness of bands by a densitometer (Alpha Imager EC Gel Doc System, CA, USA) using Alpha-View imaging software. Expression of TNF-R1 receptor protein was expressed as percentage integrated density value (%IDV) after normalization against -actin.
Statistical analysis
Difference between groups was analyzed by One-way ANOVA followed by Dunnett's Multiple Comparison (GraphPad InStat; Version 3.05). P 0.05 was considered signifi cant.
RESULTS
Coriandrum sativum hydroalcoholic extract administration reduced paw edema in carrageenan-induced paw edema model
Subplantar administration of carrageenan produced paw edema that was persistent in all the tested animals throughout the observation period. Maximum paw edema was observed at 6 h post-carrageenan administration [ Figure 1 ]. The standard drug indomethacin produced a signifi cant (P0.05) reduction in paw edema at 3 h and 6 h post-carrageenan administration. CSHE treatment produced a significant (P  0.05) reduction in paw edema at the higher two doses (16 mg/kg and 32 mg/ kg), 1 h and 3 h post-carrageenan administration. The reduction in paw edema at these two time points was greater than 40% and can be considered to be biologically signifi cant. Although the highest dose treatment (32 mg/ kg) produced a statistically signifi cant (P0.05) reduction in paw edema at 6 h post-carrageenan administration, the percentage inhibition was less than 20% and therefore, could not be considered to be biologically signifi cant.
Coriandrum sativum hydroalcoholic extract administration reduced cotton pellet implantationinduced granuloma formation
Implantation of sterile cotton pellets subcutaneously under the axilla led to the formation of granuloma tissue around the foreign body in all animals [ Figure 2 ]. Both indomethacin and CSHE (all tested doses) treatment produced a signifi cant (P  0.05) decrease in the dry granuloma weight as compared to control animals. Maximum anti-granuloma activity was observed in the 32 mg/kg CSHE-treated group.
Effect of Coriandrum sativum hydroalcoholic extract treatment on pro-infl ammatory cytokines
Circulating TNF- level in normal animals was not in the detectable range with the kit that was used in the study (U-CyTech Biosciences, The Netherlands). Subcutaneous cotton pellet implantation produced an increase in circulating TNF- level in all the tested animals [ Figure 3 ]. Indomethacin treatment produced a signifi cant (P0.05) two-fold increase in circulating TNF- level as compared to control animals. A similar increase in circulating TNF- level was also observed in the 32 mg/kg CSHE-treated group and this increase was statistically signifi cant as compared to the control.
A statistically significant decrease in circulating IL-6 level was observed in the indomethacin-treated group as compared to control [ Figure 4 ]. Although there was a slight increase in IL-1  levels in the indomethacin-treated animals as compared to control, this increase was not statistically significant [ Figure 5 ]. CSHE (32 mg/kg) treatment produced a statistically signifi cant decrease in circulating levels of both pro-infl ammatory cytokines as compared to control.
Coriandrum sativum hydroalcoholic extract administration decreased TNF-R1 protein expression in peritoneal macrophage
Initially, %IDV values were calculated separately for TNF-R1 and -actin for each sample. Thereafter, normalization of TNF-R1 protein expression in each sample was carried out by determining the amount of TNF-R1 expressed per unit of -actin ([%IDV-TNF-R1/%IDV--actin] 100).
Comparison of normalized data demonstrated a signifi cant (P  0.05) reduction in macrophage TNF-R1 protein expression in the indomethacin and CSHE (32 mg/kg)-treated groups as compared to control [ Figure 6 ]. CSHE (32 mg/kg) treatment produced a greater inhibition of TNF-R1 expression as compared to indomethacin (3 mg/kg). 
DISCUSSION
In this study, we have evaluated the pharmacological activities of CSHE in experimental models of acute inflammation and granuloma formation in rats. The carrageenan-induced paw edema model was used to evaluate the inhibitory activity of CSHE against autacoid mediators. Protection against formation of edema during the initial phase (0-2 h) is considered to depict inhibitory effect on amino acid mediators and activity during the late phase (3-6 h) is considered to be depictive of activity against arachidonic acid derivatives, mainly prostaglandins. [21] In our study, CSHE treatment at the highest dose produced a statistically signifi cant reduction in paw edema at all observation points, indicating inhibitory activity against multiple autacoid mediators.
In cotton pellet-induced granuloma model, a signifi cant (P  0.05) reduction in dry granuloma weight was observed in the CSHE-treated groups as compared to control. Cotton pellet-induced granuloma formation is considered to be a reliable experimental model for evaluation of effects on macrophage dysfunction and granuloma formation, [14, 22] central players in the formation, maintenance and progression of granulomas in various disease states. [9] Effi cacy of CSHE in this model is therefore depictive of inhibitory activity against macrophage activation, infi ltration, and aggregation. In addition, a reduction in primarily macrophage-derived pro-infl ammatory cytokines, viz., IL-6 and IL-1 , and the cytokine receptor TNF-R1 was also observed in the CSHE-treated group as compared to control animals. The effect of CSHE on cytokine profi le was slightly different from that observed with indomethacin. Both drugs increased circulating TNF- levels and decreased circulating IL-6 levels. However, while indomethacin treatment did not affect IL-1  levels, CSHE treatment produced a statistically signifi cant reduction in circulating cytokine level as compared to control. The effects observed with indomethacin on cytokine levels are similar to previously published reports. [6, 13, [23] [24] [25] Although both test and standard drug produced an increase in circulating TNF- levels, there was a statistically signifi cant reduction in peritoneal macrophage TNF-R1 expression in these two groups. This phenomenon cannot be explained at the moment and mechanistic studies will be required to delineate the same. However, this fi nding is important as most of the pathological effects of TNF- are mediated through TNF-R1. [26, 27] As CSHE is a compound formulation containing a large number of phytochemicals, it is diffi cult to attribute the observed effects to any one particular chemical moiety. However, in light of experimental evidence, at least a part of this activity could be attributed to the presence of -sitosterol and -sitosterolin in coriander seeds. [28] In experimental studies, these phytochemicals have been shown to reduce phologistic agent-induced paw edema and inhibit secretion of pro-inflammatory cytokines by macrophages. [29, 30] In our study also, a reduction was observed in IL-6, IL-1 , and TNF-R1 expression in treated animals as compared to control which could have contributed toward inhibition of macrophage activation, infi ltration, and aggregation.
The results of our present study thus validate the traditional use of CS in the management of chronic infl ammatory and granulomatous disorders. 
